Free Trial

CI Canadian Convertible Bond ETF Common (CXF) Competitors

CI Canadian Convertible Bond ETF Common logo
C$10.03
0.00 (0.00%)
(As of 11/1/2024 ET)

CXF vs. AIM, FRX, CRDL, MDNA, ITH, IPA, GXE, GPH, EQ, and WMD

Should you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include Aimia (AIM), Fennec Pharmaceuticals (FRX), Cardiol Therapeutics (CRDL), Medicenna Therapeutics (MDNA), International Tower Hill Mines (ITH), ImmunoPrecise Antibodies (IPA), Gear Energy (GXE), Graphite One (GPH), EQ (EQ), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry.

CI Canadian Convertible Bond ETF Common vs.

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Aimia (TSE:AIM) are both small-cap manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership.

CI Canadian Convertible Bond ETF Common pays an annual dividend of C$0.48 per share and has a dividend yield of 4.8%. Aimia pays an annual dividend of C$0.80 per share and has a dividend yield of 32.3%. Aimia pays out -60.2% of its earnings in the form of a dividend.

In the previous week, Aimia had 1 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 1 mentions for Aimia and 0 mentions for CI Canadian Convertible Bond ETF Common. CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 equaled Aimia'saverage media sentiment score.

Company Overall Sentiment
CI Canadian Convertible Bond ETF Common Neutral
Aimia Neutral

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than Aimia.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
AimiaC$396.20M0.62-C$117M-C$1.33-1.86

Aimia received 378 more outperform votes than CI Canadian Convertible Bond ETF Common when rated by MarketBeat users. However, 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote while only 54.18% of users gave Aimia an outperform vote.

CompanyUnderperformOutperform
CI Canadian Convertible Bond ETF CommonOutperform Votes
11
57.89%
Underperform Votes
8
42.11%
AimiaOutperform Votes
389
54.18%
Underperform Votes
329
45.82%

31.6% of Aimia shares are owned by institutional investors. 3.3% of Aimia shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Aimia has a consensus target price of C$4.00, suggesting a potential upside of 61.29%. Given Aimia's higher probable upside, analysts plainly believe Aimia is more favorable than CI Canadian Convertible Bond ETF Common.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CI Canadian Convertible Bond ETF Common
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Aimia
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

CI Canadian Convertible Bond ETF Common has a net margin of 0.00% compared to Aimia's net margin of -26.20%. CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Aimia's return on equity.

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
Aimia -26.20%-16.59%-4.93%

Summary

Aimia beats CI Canadian Convertible Bond ETF Common on 9 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CXF vs. The Competition

MetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE Exchange
Market CapC$61.15MC$7.02BC$2.14BC$5.94B
Dividend Yield4.99%7.97%2.67%5.37%
P/E RatioN/A9.5027.5225.87
Price / SalesN/A386.17174.221,515.70
Price / CashN/A47.320.2681.06
Price / BookN/A5.321.433.11
Net IncomeN/AC$153.56MC$257.43MC$292.76M
7 Day Performance-0.69%0.12%-0.70%-1.65%
1 Month Performance-0.40%15.23%-0.93%2.32%
1 Year Performance14.24%41.16%13.37%45.73%

CI Canadian Convertible Bond ETF Common Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CXF
CI Canadian Convertible Bond ETF Common
N/AC$10.03
flat
N/A+14.2%C$61.15MN/A0.0090
AIM
Aimia
1.6468 of 5 stars
C$2.49
-0.4%
C$4.00
+60.6%
-22.3%C$244.97MC$396.20M-1.8720Upcoming Earnings
News Coverage
FRX
Fennec Pharmaceuticals
N/AC$6.79
+3.7%
N/A-35.3%C$185.77MC$48.89M67.9010Upcoming Earnings
News Coverage
CRDL
Cardiol Therapeutics
N/AC$2.57
flat
N/A+125.0%C$179.59MN/A-5.8420News Coverage
MDNA
Medicenna Therapeutics
N/AC$2.30
-1.7%
N/A+1,040.9%C$175.79MN/A-6.0520
ITH
International Tower Hill Mines
N/AC$0.86
+1.2%
N/A+61.5%C$171.73MN/A-28.67220News Coverage
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
GXE
Gear Energy
2.9725 of 5 stars
C$0.54
+1.9%
C$1.00
+85.2%
-36.6%C$142.33MC$134.93M10.801,310Dividend Announcement
News Coverage
GPH
Graphite One
N/AC$0.87
+1.2%
N/A-18.8%C$120.57MN/A-12.4320
EQ
EQ
N/AC$1.10
+0.9%
N/A+35.0%C$76.55MC$9.86M-15.7140
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up

Related Companies and Tools


This page (TSE:CXF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners